Evidence map›Paper›PMID 38225350›Full record

ArticleCellular & molecular immunology2024

Not to be and how not to be: the questions of Tregs controlled by RIPK1.

Zhengcai Peng, Huiyuan Zhang, Hongbo Hu

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular & molecular immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Zhengcai PengCenter for Immunology and Hematology, Department of Biotherapy and Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Huiyuan ZhangCenter for Immunology and Hematology, Department of Biotherapy and Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. hyzhang@scu.edu.cn.ORCID http://orcid.org/0000-0002-1532-2462
Hongbo HuCenter for Immunology and Hematology, Department of Biotherapy and Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. hongbohu@scu.edu.cn.ORCID http://orcid.org/0000-0002-8177-7641

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32230036National Natural Science Foundation of China (National Science Foundation of China) 82025002National Natural Science Foundation of China (National Science Foundation of China) 82170113
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Receptor-Interacting Protein Serine-Threonine KinasesT-Lymphocytes, RegulatoryCell DeathHomeostasisReceptor-Interacting Protein Serine-Threonine Kinases

Identifiers

PMID38225350
PMCPMC10805722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.